ANGLE plc (ANGLE) is a holding commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company�s principal subsidiaries are Parsortix Inc (Parsortix) and Novocellus Limited, which are commercially driven specialist medical diagnostics companies with pioneering products in cancer diagnostics and foetal health. ANGLE also owns a major investment in Geomerics Limited, a business with a computer graphics technology platform, and a specialist technology consultancy. The Company operates in four segments: Controlled investments in medical diagnostics, Non-controlled investments, Ventures and Management services. ANGLE has developed its Parsortix technology to capture circulating tumor cells (CTCs) in cancer patient blood. In December 2013, ANGLE plc sold Geomerics Limited to ARM Holdings plc.